MedTrace Logo

DAPHNE Scale Validation in Frontotemporal Lobar Degeneration

NCT02889601 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2017-08-21

No results posted yet for this study

Summary

Psycho-behavioral disorders assessment is crucial for the diagnosis and follow-up of patients with frontotemporal degeneration (FTD). DAPHNE scientific staff have therefore developed a quantification and follow-up scale specifically dedicated to patients with FTD in current clinical practice. This scale is called DAPHNE to Disinhibition, Apathy, Perseveration, Hyper orality, Negligence and loss of Empathy.

Conditions

  • Frontotemporal Lobar Degeneration

Interventions

OTHER

Psycho-behavioural assessment

DAPHNE Scale

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2013-12-31
Completion
2015-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02889601 on ClinicalTrials.gov